| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/29/1998 | EP0854715A1 Methods of inhibiting plasminogen activator inhibitor 1 |
| 07/29/1998 | EP0854711A1 gamma-RAR ANTAGONIST LIGAND OR alpha-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR |
| 07/29/1998 | EP0794949B1 Novel 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives, their preparation and use as drugs |
| 07/29/1998 | EP0740668B1 Tetracyclic derivatives, process of preparation and use |
| 07/29/1998 | EP0722434B1 Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation |
| 07/29/1998 | EP0589908B1 Aminoalkyl-substituted thiazolin-2-ones, their preparation and their use |
| 07/29/1998 | CN1189166A Somatostatin peptides |
| 07/29/1998 | CN1189156A Quinoline derivatives containing a diol as leukotriene antagonists |
| 07/29/1998 | CN1189151A 维生素d类似物 Vitamin d analogues |
| 07/29/1998 | CN1188760A Benzidine-sulfuryl radical substitution pentatomic heterocycle, its preparation method, its medicinal and composition |
| 07/29/1998 | CN1188645A Process for preparing pharmaceutical composition for treatment or prevention hypertension |
| 07/29/1998 | CN1039324C Substituted nitrogen heterocyclic pyrimidines compound preparation method of medicinal salt or N-oxide |
| 07/28/1998 | US5786379 Adamantyl-substituted biaromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 07/28/1998 | US5786372 Heteroaryl compounds used as pharmaceuticals |
| 07/28/1998 | US5786361 Antiatherosclerosic agents |
| 07/28/1998 | US5786360 Antiallergens, central nervous system stimulants, diuretics, antihistamines, cardiotonic agents; water solubility |
| 07/28/1998 | US5786355 4,6-diarylpyrimidine derivatives and salts thereof |
| 07/28/1998 | US5786347 Vitamin D amine and amide derivatives |
| 07/28/1998 | US5786330 Polypeptides as anticoagulants |
| 07/28/1998 | US5786326 Administering desferri-exochelin |
| 07/28/1998 | US5786197 lep |
| 07/28/1998 | US5785967 Antibodies immunoreactive with leukemia inhibitory factor receptors |
| 07/28/1998 | CA2220851A1 Cdna clone he8ch90 that encodes a novel 7-transmembrane receptor |
| 07/28/1998 | CA2141563C Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
| 07/28/1998 | CA2105072C Morphinan derivative and its pharmaceutical applications |
| 07/23/1998 | WO1998031798A1 Human extracellular matrix-1 |
| 07/23/1998 | WO1998031709A1 Antibodies that bind to the nidogen-binding domain of laminin, their production and use |
| 07/23/1998 | WO1998031702A1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 07/23/1998 | WO1998031680A1 1,4-dihydropyridin derivatives and their use in therapy |
| 07/23/1998 | WO1998031670A1 Thrombin inhibitors |
| 07/23/1998 | WO1998031399A2 LABELLED FACTOR XIIIa SUBSTRATES |
| 07/23/1998 | WO1998031381A1 Compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants |
| 07/23/1998 | WO1998031366A1 Method for treating atherosclerosis with an mpt inhibitor and cholesterol lowering drugs |
| 07/23/1998 | WO1998031359A1 Integrin antagonists |
| 07/23/1998 | WO1998012334A3 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin |
| 07/23/1998 | WO1998012329A3 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin |
| 07/23/1998 | DE19701607A1 Anitkörper, die an die Nidogen-Bindungsdomäne des Laminins binden, deren Herstellung und Verwendung Anitkörper that bind to the nidogen-binding domain of laminin, their preparation and use |
| 07/23/1998 | CA2403927A1 Human extracellular matrix-1 |
| 07/23/1998 | CA2278477A1 Antibodies that bind to the nidogen-binding domain of laminin, their production and use |
| 07/23/1998 | CA2278055A1 Human extracellular matrix-1 |
| 07/23/1998 | CA2277929A1 Thrombin inhibitors |
| 07/23/1998 | CA2277924A1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 07/23/1998 | CA2276467A1 Method for treating atherosclerosis with an mpt inhibitor and cholesterol lowering drugs |
| 07/22/1998 | EP0854191A2 Human cardiac/brain tolloid-like protein |
| 07/22/1998 | EP0854145A2 Vitronectin receptor antagonists, their production and their use |
| 07/22/1998 | EP0854140A2 Vitronectin receptor antagonists, their production and their use |
| 07/22/1998 | EP0853673A1 COMPOUND HAVING SEQUENCE HOMOLOGY WITH LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 (Lp-PLA2)/PAF ACETYL HYDROLASE |
| 07/22/1998 | EP0853614A1 Substituted tetralylmethylen-oxindole analogues as tyrosine kinase inhibitors |
| 07/22/1998 | EP0853485A1 Therapeutic administration of hemoglobin in cardiac arrest |
| 07/22/1998 | EP0853480A1 Use of a thienotriazolodiazepine to increase apolipoprotein a-i levels |
| 07/22/1998 | EP0853479A1 ALPHA 1b ADRENERGIC RECEPTOR ANTAGONISTS |
| 07/22/1998 | EP0853477A1 At1-receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys |
| 07/22/1998 | EP0736025B1 Dyhydrobenzofuranyl-biphenyl carboxamides having 5ht1d antagonistic activity |
| 07/22/1998 | EP0656029B1 Crosslinked polymeric ammonium salts |
| 07/22/1998 | CN1188412A Means for treating radiation injuries |
| 07/22/1998 | CN1187996A Drug for curing cerebral infarction |
| 07/22/1998 | CA2227112A1 Five-membered heterocycles having biphenylsulfonyl substitution, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 07/21/1998 | US5783705 Process of preparing alkali metal salys of hydrophobic sulfonamides |
| 07/21/1998 | US5783600 Carboxyalkylethers, formulations, and treatment of vascular diseases |
| 07/21/1998 | US5783590 6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenz CD!indoles |
| 07/21/1998 | US5783576 Benzoyl guanidine derivatives, the preparation thereof and their use in pharmaceutical compositions |
| 07/21/1998 | US5783215 Pharmaceutical preparation |
| 07/21/1998 | CA2224910A1 Cardiac diseases improving agents |
| 07/16/1998 | WO1998030707A2 Eukaryotic gene expression cassette and uses thereof |
| 07/16/1998 | WO1998030693A2 Tumor necrosis factor receptor 5 |
| 07/16/1998 | WO1998030692A2 Human endosulfine gene |
| 07/16/1998 | WO1998030683A2 Nuclear transfer with differentiated fetal and adult donor cells |
| 07/16/1998 | WO1998030586A2 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 07/16/1998 | WO1998030561A1 2-(1,2,4-triazole-1-yl)-1,3,4-thiadiazole derivatives having an effect on the c.n.s. and the heart |
| 07/16/1998 | WO1998030542A1 Vitronectin receptor antagonists |
| 07/16/1998 | WO1998030231A1 Use of exendins and agonists thereof for the reduction of food intake |
| 07/16/1998 | WO1998030218A1 Substituted bis-acridines and related compounds as ccr5 receptor ligands, anti-inflammatory agents and anti-viral agents |
| 07/16/1998 | WO1998030216A1 Use of angiotensin ii antagonists to treat symptomatic heart failure |
| 07/16/1998 | WO1998030147A1 Composition containing a radioactive component for treatment of vessel wall |
| 07/16/1998 | CA2278330A1 Composition containing a radioactive component for treatment of vessel wall |
| 07/16/1998 | CA2278326A1 Eukaryotic gene expression cassette and uses thereof |
| 07/16/1998 | CA2277910A1 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 07/16/1998 | CA2276738A1 Vitronectin receptor antagonists |
| 07/16/1998 | CA2276720A1 2-(1,2,4-triazole-1-yl)-1,3,4-thiadiazole derivatives having an effect on the c.n.s. and the heart |
| 07/16/1998 | CA2276533A1 Human endosulfine gene |
| 07/16/1998 | CA2276525A1 Substituted bis-acridines and related compounds as ccr5 receptor ligands, anti-inflammatory agents and anti-viral agents |
| 07/15/1998 | EP0853125A2 cDNA clone HNFJD15 that encodes a human 7-transmembrane receptor |
| 07/15/1998 | EP0853084A2 Substituted purine derivatives as vitronectin receptor antagonists |
| 07/15/1998 | EP0853083A1 Pyridylfuran and pyridylthiophene compounds and pharmaceutical use thereof |
| 07/15/1998 | EP0852495A1 Pharmaceutical compositions containing hydroximic acid derivatives |
| 07/15/1998 | EP0852491A1 Use of heparinases to decrease inflammatory responses |
| 07/15/1998 | EP0719263B1 Heterocyclic carboxamide derivatives with antiarrhythmic activity |
| 07/15/1998 | EP0696190B1 Nasal aromatic releasing compositions |
| 07/15/1998 | CN1187821A Rapamycin derivatives |
| 07/15/1998 | CN1187490A 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists |
| 07/15/1998 | CN1187356A Stable prescription and process of fleabane extract injection |
| 07/15/1998 | CN1187352A Medicine composition of saponin containing protopanaxyndiol component and preparing process and application thereof |
| 07/15/1998 | CN1039126C Tachiquinine antagonist tricyclic compounds and pharmaceutical compositions containing such compounds |
| 07/15/1998 | CN1039124C Partially modified and retro-inverted tetrapeptides analogues of c-reactive protein fragments and medicinal composition |
| 07/15/1998 | CN1039120C N-££1-£4(4-fluorophenoxy) butyl|-4-piperidinyl|-n-methylamino|-2-benzothiazolols as class III antiarr hythmic agents |
| 07/14/1998 | US5780648 Benzothiophene compounds, and uses formulations thereof |
| 07/14/1998 | US5780636 Process for thiopyrans |
| 07/14/1998 | US5780615 Glycosylation of lipids and lipid-containing particles and diagnostic and therapeutic methods and materials derived therefrom |
| 07/14/1998 | US5780611 Oligonucleotide which binds with double-stranded promoter region of human collagen gene to form triple helix complex |
| 07/14/1998 | US5780590 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |